期刊文献+

冠心病患者血浆中单核细胞趋化蛋白-1的意义 被引量:13

Significance of plasma monocyte chemotactic protein-1 in patients with coronary heart disease
原文传递
导出
摘要 目的:观察冠心病患者血浆中单核细胞趋化蛋白-1(MCP-1)的浓度,探讨其诊断冠心病的意义及临床价值。方法:将122例患者分为非冠心病组(30例)、稳定型心绞痛组(32例)、不稳定型心绞痛组(27例)和急性心肌梗死组(33例),应用酶联免疫吸附法检测患者血浆中MCP-1、组织因子(TF)的浓度。结果:①血浆中MCP-1、TF的浓度均为:非冠心病组<稳定型心绞痛组<不稳定型心绞痛组<急性心肌梗死组(均P<0.05)。②血浆中MCP-1的浓度与患者的性别、吸烟、冠心病家族史、高血压和糖尿病、TG、HDL-C、尿素氮、肌酐无明显相关性(均P>0.05),与年龄、体质指数、TC、LDL-C、尿酸、心肌肌钙蛋白I、肌酸激酶同工酶、TF呈正相关性(均P<0.05)。③以血浆中MCP-1的浓度作为诊断急性冠状动脉综合征的指标,ROC曲线分析结果显示MCP-1的诊断价值较大,曲线下面积0.939(P<0.05),最佳临界值为320.5ng/L,其特异度和灵敏度分别是86.7%和88.0%。结论:血浆中MCP-1在判断冠状动脉粥样硬化斑块易损性方面有一定的临床意义,可能是冠心病的一个独立危险因素,可作为诊断急性冠状动脉综合征的理想指标。 Objective:To investigate the significance and clinical value of plasma monocyte chemotactic protein-1(MCP-1) in diagnosis of coronary heart disease(CHD) by observation of the concentrations of plasma MCP-1 in patients with CHD.Method:One hundred and twenty-two patients were divided into Non-CHD group(control group,n=30),SAP group(n=32),UAP group(n=27) and AMI group(n=33).In all these groups,the concentrations of plasma MCP-1 and tissue factor(TF) in the patients were detected by ELLSA.Result:①The concentrations of plasma MCP-1 and TF were: control group〈SAP group〈UAP group〈AMI group(all P〈0.05).②The concentrations of plasma MCP-1 was not correlated with gender,smoking status,history of CHD,hypertension,diabetes,TG,HDL-C,urea nitrogen and creatinine(all P〈0.05),but it was positively correlated with age,BMI,TC,LDL-C,uric acid,cTnI,CK-MB and TF(all P〈0.05).③Using concentration of plasma MCP-1 as a diagnostic indicator of acute coronary syndrome,ROC curve analysis showed that MCP-1 had diagnostic value,the area under ROC curve of MCP-1 was 0.939(P〈0.05),the best critical concentration of plasma MCP-1 was 320.5 ng/L,the specificity and sensitivity were 86.7% and 88.0%.Conclusion:Plasma MCP-1 may have clinical significance in reflecting the vulnerability of atherosclerotic plaque,it may be an independent risk factor of CHD and a good indicator in diagnosis of acute coronary syndrome.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2012年第5期367-370,共4页 Journal of Clinical Cardiology
关键词 冠心病 单核细胞趋化蛋白-1 组织因子 危险因素 相关性 coronary heart disease MCP-1 tissue factor risk factors correlation
  • 相关文献

参考文献16

  • 1WU A H. The ischemia-modified albumin biomarker for myocardial ischemia[J]. MLO Med Lab Obs, 2003,35.. 36-38,40.
  • 2CHARO I F, RANSOHOFF R M. The many roles of chemokines and chemokine receptors in inflammation[J].NEnglJ Med,2006,354:610--621.
  • 3VIOLA A, LUSTER A D. Chemokines and their receptors : drug targets in immunity and inflammation[J]. Annu Rev Pharmacol Toxicol ,2008,48:171-197.
  • 4LIBBY P. Inflammation in atherosclerosis[J]. Nature, 2002,420:868-874.
  • 5CROCE K, LIBBY P. Intertwining of thrombosis and inflammation in atherosclerosis[J]. Curr Opin Hematol,2007,14:55-61.
  • 6STRUKOVA S. Blood coagulation-dependent inflam- mation. Coagulation-dependent inflammation and in- flammation-dependent thrombosis[J]. Front Biosci, 2006,11 :59-80.
  • 7LEVI M, VAN DER POLL T, TEN CATE H. Tissue factor in infection and severe inflammation[J]. Semin Thromb Hemost, 2006,32 : 33 - 39.
  • 8VIEDT C, VOGEL J, ATHANASIOU T, et al. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1[J].Arterioscler Thromb Vasc Biol, 2002, 22:914-920.
  • 9WERLE M, SCHMAL U, HANNA K, et al. MCP- 1 induces activation of MAP-kinases ERK, JNK and p38 MAPK in human endothelial cells[J]. Cardiovasc Res, 2002,56 : 284-292.
  • 10MUKAIDA N, HARADA A, MATSUSHIMA K. Interleukin-8 (IL- 8) and monocyte chemotactic and activating factor (MCAF/MCP-1) chemokines essentially involved in inflammatory and immune reactions [J]. Cytokine Growth Factor Rev, 1998,9:9-23.

同被引文献119

引证文献13

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部